Home  /   News  /   Company News
A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting TRPA1: Molecular Therapy - Nucleic Acids
30/11/2022


A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting TRPA1: Molecular Therapy - Nucleic Acids.pdf

Back to List
More Press Releases
2022-08-08
PolyU collaborates with Increasepharm (HK) Limited for CM-based new drug development
Full text
2022-08-08
Reviewer Guidance for Nebulizers, Metered Dose Inhalers, Spacers and Actuators
Full text
2021-08-08
Hydrogen Peroxide Nebulization and COVID Resolution
Full text
2021-08-08
In situ gel-forming system: an attractive alternative for nasal drug delivery
Full text
2020-08-08
Research and Application of In-situ Gel Preparation
Full text